Canagliflozin vs Osimertinib

Canagliflozin vs Osimertinib: Overview

This comparison examines the pharmacological differences between Canagliflozin and Osimertinib.

Mechanism of Action

Canagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Canagliflozin — 10.6 hours; Osimertinib — 48 hours.

Chemical Properties

Molecular Formula: Canagliflozin — C24H25FO5S; Osimertinib — C28H33N7O2.

Molecular Weight: Canagliflozin — 444.5170 g/mol; Osimertinib — 499.6050 g/mol.

Type: Canagliflozin — Small molecule; Osimertinib — Small molecule.